Article ID | Journal | Published Year | Pages | File Type |
---|---|---|---|---|
9261930 | Best Practice & Research Clinical Rheumatology | 2005 | 8 Pages |
Abstract
The outcome of systemic necrotizing vasculitides, with treatment, has improved over the past few decades, with a 5 year survival rate that currently exceeds 80%. It is now well established that therapy has to be adapted to aetiology, pathogenesis and disease severity, but complementary measures can also be beneficial, for example systematic prophylaxis against infections and/or adjusting drug doses to biological parameters and the patient's general condition, especially for the elderly and those in intensive care units. A multifaceted and point-by-point approach to patient care is needed to further improve quality of life whenever possible.
Keywords
Related Topics
Health Sciences
Medicine and Dentistry
Immunology, Allergology and Rheumatology
Authors
Christian MD, Loïc MD,